skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of a Unique Inhibitor-Binding Site on Choline Kinase α

Journal Article · · Biochemistry
 [1];  [2]; ORCiD logo [3]
  1. Univ. of Illinois at Chicago, IL (United States)
  2. Univ. of Pennsylvania, Philadelphia, PA (United States)
  3. Univ. of Illinois at Chicago, IL (United States); The Jesse Brown VA Medical Center, Chicago, IL (United States)

Choline kinase α (ChoKα) is an enzyme that is upregulated in many types of cancer and has been shown to be tumorigenic. As such, it makes a promising target for inhibiting tumor growth. Though there have been several inhibitors synthesized for ChoKα, not all of them demonstrate the same efficacy in vivo, though the reasons behind this difference in potency are not clear. One particular inhibitor, designated TCD-717, has recently completed phase I clinical trials. Cell culture and in vitro studies support the powerful inhibitory effect TCD-717 has on ChoKα, but an examination of the inhibitor’s interaction with the ChoKα enzyme has been missing prior to this work. Here we detail the 2.35 Å structure of ChoKα in complex with TCD-717. Examination of this structure in conjunction with kinetic assays reveals that TCD-717 does not bind directly in the choline pocket as do previously characterized ChoKα inhibitors, but rather in a proximal but novel location near the surface of the enzyme. Here, the unique binding site identified for TCD-717 lends insight for the future design of more potent in vivo inhibitors for ChoKα.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; National Inst. of Health
Grant/Contract Number:
AC02-06CH11357; 085P1000817; RO1 EB013685; R01 EB018645
OSTI ID:
1432889
Journal Information:
Biochemistry, Vol. 57, Issue 8; ISSN 0006-2960
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 18 works
Citation information provided by
Web of Science

References (28)

Structure and function of choline kinase isoforms in mammalian cells journal May 2004
Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1 journal June 2015
Choline kinase alpha—Putting the ChoK-hold on tumor metabolism journal July 2016
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis journal July 2005
Discovery of a New Binding Site on Human Choline Kinase α1: Design, Synthesis, Crystallographic Studies, and Biological Evaluation of Asymmetrical Bispyridinium Derivatives journal September 2013
Choline kinase inhibitors as a novel approach for antiproliferative drug design journal November 1997
Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery journal January 2016
Determination of Potential Scaffolds for Human Choline Kinase α1 by Chemical Deconvolution Studies journal June 2013
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers journal August 2002
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation journal August 2011
Magnetic Resonance Spectroscopy for Detection of Choline Kinase Inhibition in the Treatment of Brain Tumors journal February 2015
Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma journal August 2016
Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells journal December 2014
Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival: Role of choline kinase-alpha in breast cancer journal October 2015
Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3: SINGLE AMINO ACID NEAR THE ACTIVE SITE INFLUENCES INHIBITOR SENSITIVITY journal March 2010
Elucidation of Human Choline Kinase Crystal Structures in Complex with the Products ADP or Phosphocholine journal November 2006
Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models journal January 2006
Choline metabolism in malignant transformation journal November 2011
Structure-activity aspects of hemicholinium-3 (HC-3) and its analogs and congeners journal September 1994
A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival journal March 2013
Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy journal June 2002
XDS journal January 2010
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) journal March 2016
Antiplasmodial Activity and Mechanism of Action of RSM-932A, a Promising Synergistic Inhibitor of Plasmodium falciparum Choline Kinase journal September 2013
The Mechanism of Allosteric Coupling in Choline Kinase α1 Revealed by the Action of a Rationally Designed Inhibitor journal February 2013
Kinetic and mechanistic characterisation of Choline Kinase-α journal June 2013
Choline Phosphokinase journal May 1953

Cited By (3)

Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase journal November 2019
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer journal August 2018
Causes, consequences, and therapy of tumors acidosis journal March 2019